News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Sameer Raastogi Shared Phase 2 Trial Results For Low-dose Regorafenib in Relapsed Synovial Sarcoma
Sameer Rastogi/X
Jun 12, 2025, 15:42

Sameer Raastogi Shared Phase 2 Trial Results For Low-dose Regorafenib in Relapsed Synovial Sarcoma

Sameer Rastogi, Additional Professor at All India Institute of Medical Sciences, shared a post on X:

“Pleased to share Phase 2 trial results for low-dose regorafenib in relapsed synovial sarcoma. N=25, 76% previously exposed to pazopanib. 3-month progression-free rate: 56%. Median progression-free survival: 5 mths.”

Title: Efficacy and Tolerability of a Low-Dose Continuous Regimen of Regorafenib in Refractory Synovial Sarcomas: A Single-Arm, Phase II Trial From India

Authors: Sanal Fernandes, Sameer Rastogi, Kanu Priya Bhatia, Shamim A. Shamim, Adarsh Barwad, Rambha Pandey, Shivanand Gammanagatti, Ekta Dhamija

Read Full Article.

Low-dose Regorafenib

More posts featuring Sameer Rastogi on OncoDaily.

cancer OncoDaily Oncology regorafenib Sameer Rastogi
Special Coverage
Blog
Jun 12, 2025, 15:42
Sameer Raastogi Shared Phase 2 Trial Results For Low-dose Regorafenib in Relapsed Synovial Sarcoma
Science
Jun 12, 2025, 15:38
Adding Immunotherapy to Standard Chemotherapy Extends Quality of Life for Patients with Advanced Endometrial Cancer
Insight
Jun 12, 2025, 15:34
ESMO TAT 2026: Dates, Location, Registration, and What to Expect
Insight
Jun 12, 2025, 15:30
Caryn Lerman Highlighted Study Published in Viruses on WAVE1 and WAVE2 Roles in HPV16 Cell Entry
Blog
Jun 12, 2025, 15:30
Wafaa M Rashed: More Incredible News from the PAPERI Family
Science
Jun 12, 2025, 15:26
Sergio Cifuentes Canaval Shares Key Insights on Clinical Trial Barriers Related to Race and Older Age
Blog
Jun 12, 2025, 15:12
Hassan R Hashmi Reflects on National Cancer Survivors Month 2025
Stories
Jun 12, 2025, 14:43
Three Years After Neuroblastoma Diagnosis, Bodie Is Thriving – St. Baldrick's Foundation Shared Bodie's Story
Blog
Jun 12, 2025, 14:27
Register for "Empathy in Cancer Treatment and Compassion Fatigue" Virtual Event on June 25 - European Cancer Organisation
Blog
Jun 12, 2025, 14:22
Prisca Githuka About Uterine Cancer Signs After Menopause
Insight
Jun 12, 2025, 14:10
Yan Leyfman: Breakthrough in Solid Tumor CAR T Therapy
Blog
Jun 12, 2025, 14:08
Register for 2nd National Cancer Summit hosted by the National Cancer Institute of Kenya